Bulbo-medullary abscess’s management

Current management of medullary thyroid cancer.

Medullary thyroid cancer accounts for 5%-10% of all thyroid cancers. The majority of medullary thyroid cancers are sporadic, but 20% of cases are a result of a germline mutation in the ret proto-oncogene. Hereditary medullary thyroid cancer can be seen as part of the multiple endocrine neoplasia syndrome type 2A or 2B or as part of familial medullary thyroid cancer. This article discusses the c...

The surgical management of medullary thyroid cancer.

Medullary thyroid cancer (MTC), accounts for approximately 5% to 10% of all thyroid cancers. Significant advances in the understanding of the biology and clinical outcomes of MTC have been made over the last decade, culminating most recently in the publication of treatment guidelines by the American Thyroid Association that follow an evidence-based approach that is summarized in this presentati...

Advanced medullary thyroid cancer: pathophysiology and management

Medullary thyroid carcinoma (MTC) is a rare malignant tumor originating from thyroid parafollicular C cells. This tumor accounts for 3%-4% of thyroid gland neoplasias. MTC may occur sporadically or be inherited. Hereditary MTC appears as part of the multiple endocrine neoplasia syndrome type 2A or 2B, or familial medullary thyroid cancer. Germ-line mutations of the RET proto-oncogene cause here...

Mechanism of Slow Conduction at the Bulbo-ventricular Junction.

• Delay in atrioventricular conduction has been attributed mainly to slow conduction of excitation at the prenodal tissue of the A-V node." Electrophysiological studies of this prenodal tissue have revealed several common physiological properties, such as low amplitude and overshoot of action potential, low resting potential, low rate of depolarization and low conduction velocity which are spec...

Infections of the Bulbo-Urethral Glands of Cowper.